Selz Capital’s Allergan plc AGN Stock Holding History

Selz Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,000	Closed	-$4.78M	–	53
2017 Q1	$4.78M	Sell	20,000 -15,000	-43%	-$3.49M	1.24%	20
2016 Q4	$7.35M	Sell	35,000 -10,000	-22%	-$2.07M	1.89%	13
2016 Q3	$10.4M	Hold	45,000	–	–	2.41%	11
2016 Q2	$10.4M	Sell	45,000 -10,000	-18%	-$2.31M	2.96%	11
2016 Q1	$14.7M	Sell	55,000 -25,000	-31%	-$7.16M	4.48%	5
2015 Q4	$25M	Buy	80,000 +40,000	+100%	+$11.9M	7.23%	4
2015 Q3	$10.9M	Sell	40,000 -94,000	-70%	-$28.9M	3%	10
2015 Q2	$40.7M	Hold	134,000	–	–	7.34%	2
2015 Q1	$39.9M	Buy	134,000 +25,000	+23%	+$7.13M	6.87%	2
2014 Q4	$28.1M	Buy	109,000 +19,000	+21%	+$4.75M	8.79%	2
2014 Q3	$21.7M	Sell	90,000 -10,000	-10%	-$2.24M	7.05%	3
2014 Q2	$22.3M	Hold	100,000	–	–	5.91%	3
2014 Q1	$20.6M	Hold	100,000	–	–	5.17%	3
2013 Q4	$16.8M	Hold	100,000	–	–	4.21%	4
2013 Q3	$14.4M	Hold	100,000	–	–	4.21%	5
2013 Q2	$12.6M	Buy	+100,000	New	+$11.3M	3.59%	7

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Selz Capital's AGN Position: Q2 2017 in Review

Selz Capital sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 20,000 shares — an estimated $4.78M sold.

Selz Capital first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $40.7M in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

Selz Capital reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
Selz Capital sold 20,000 Allergan plc shares in Q2 2017, an estimated $4.78M.
Selz Capital first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
Selz Capital's Allergan plc position peaked at $40.7M in Q2 2015.
1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Selz Capital's 13F filing for Q2 2017, filed 25 Jul 2017.